Due to the relevance of tumor-infiltrating T lymphocytes in the anti-cancer immune response, we further assessed TMEM123 expression in CD8+ and CD4+ T lymphocytes infiltrating CRC tissues by multiple immunofluorescence confocal microscopy on cryopreserved CRC tissues (N=4 samples). The gene discussed is CD4; the disease is cancer.